the clinical potentials of stem cells in cell-based therapies have raised great hopes in diabetes mellitus as well. however, there are complex ethical, legal, and socio-cultural issues surrounding the subject. in this paper, we intend to review in brief the main ethical issues for endocrinologists and other clinicians who are interested and work in the field of cell therapy and research.

Allogenic stem cell transplant (SCT) and bone marrow (BMT) are curative of conditions including Leukemias, Sickle disease, Thalassemia. Cutaneous manifestations in a post-transplant patient may be an early sign acute graft versus host disease (aGvHD), serious potentially life-threatening reaction to the transplant. Other causes can include medications, reactivation latent viral infections, owin...

We are celebrating one millionth transplant in year 2013! With continued improvement in hematopoietic cell transplantation (HCT) outcome, the indications for HCT continue to grow. Furthermore the sources of stem cells and the number of suitable matches are expanding. At the same time, modified transplantation regimens have facilitated safer procedures despite increase in patient's age and comor...